Diagnostics

  • Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Labcorp closes takeover of Empire City assets to fuel New York expansion

    The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

    By • Feb. 11, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA breakthrough program starts FY2026 at steady pace

    Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.

    By • Feb. 9, 2026
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendlineâž”
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Medicare enrollment form and money.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Genetic testing takes greater share of Medicare Part B test spending: OIG

    Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.

    By • Feb. 4, 2026
  • A Grail employee in a white coat works in a lab.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    Grail files for FDA approval of multi-cancer early detection test

    Premarket approval could help the company secure coverage from commercial payers and Medicare.

    By • Feb. 2, 2026
  • Michael Iskra, wearing a navy blue jacket and light blue shirt, smiles in a head shot.
    Image attribution tooltip
    Permission granted by Cleveland Diagnostics
    Image attribution tooltip

    Cleveland Diagnostics names Michael Iskra CEO

    Iskra will help Cleveland Diagnostics scale up commercial adoption of its IsoPSA blood-based test that analyzes the structure of protein biomarkers for prostate cancer signals.

    By • Jan. 29, 2026
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson
    Image attribution tooltip

    BD, Waters set completion date for $17.5B biosciences and diagnostics merger

    With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.

    By • Jan. 28, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • A close-up image of an Nvidia chip on a computer motherboard.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Trump issues 25% tariffs on narrow range of semiconductors

    The levies, effective Jan. 15, do not cover products used for data centers and consumer applications, per a proclamation signed Wednesday.

    By Antone Gonsalves , Phil Neuffer • Jan. 15, 2026
  • A sign that says Illumina is on a curb in front of red brick buildings.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    Illumina names former NIH genomics director as chief medical officer

    The company unveiled the appointment alongside news of the departure of its chief commercial officer.

    By • Jan. 12, 2026
  • A person wearing scrubs, a mask and a cap looks at a screen with images.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips to acquire SpectraWAVE

    SpectraWAVE makes technologies to help diagnose and guide treatment decisions for coronary artery disease.

    By • Dec. 15, 2025
  • An illustration of DNA against a blue abstract background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Natera acquires Foresight Diagnostics for up to $450M

    Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in 2026.

    By • Dec. 10, 2025
  • A person covered by a blue sheet lays flat under a rectangular, white tube.
    Image attribution tooltip
    Courtesy of Mayo Clinic
    Image attribution tooltip

    GE HealthCare, Mayo Clinic expand partnership around radiology research

    Ben Newton, GE HealthCare’s global head of oncology, said the partnership will shift radiation therapy from a “one-size-fits-all” approach to a personalized method.

    By • Dec. 9, 2025
  • The building features a modern glass façade with the Nasdaq logo prominently displayed. Surrounding the structure are other commercial buildings and digital billboards, which are characteristic of the vibrant Times Square environment.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Freenome inks deals to list stock and raise $330M

    The company plans to use the proceeds to expand its commercial and data infrastructure to support the launch of multiple blood-based cancer detection tests.

    By • Dec. 8, 2025
  • Two young scientists conducting medical research in a laboratory.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CHS sells lab assets to Labcorp for $194M

    The deal, first announced in July, includes outreach laboratory services in 13 states. CHS will continue to operate inpatient and emergency department labs.

    By Susanna Vogel • Dec. 4, 2025
  • A warehouse with rows of packages
    Image attribution tooltip
    Courtesy of Medline
    Image attribution tooltip

    PitchBook: AI tuck-in deals to drive M&A acceleration in 2026

    Buyers will focus on “tuck-ins that add AI or data-driven capabilities or can meaningfully improve scale against emerging competitors,” the analysts said.

    By • Dec. 3, 2025
  • A Cleveland Diagnostics lab technician wearing a white coat and blue gloves analyzes results from an IsoPSA sample in a lab.
    Image attribution tooltip
    Permission granted by Cleveland Diagnostics
    Image attribution tooltip

    Cleveland Diagnostics wins FDA nod for prostate cancer test

    The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy procedure.

    By • Dec. 2, 2025
  • Senior Research Associate Tanya Quint loads one of the instruments used to run Exact Sciences' Cologuard test at the company's headquarters in Madison, Wis. (Photo: Business Wire)
    Image attribution tooltip
    Courtesy of Business Wire/Exact Sciences
    Image attribution tooltip

    Abbott’s $21B Exact Sciences buy reveals future strategy

    The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing. 

    By • Nov. 21, 2025
  • A sign spelling Roche hangs on the side of a building.
    Image attribution tooltip
    Sedat Suna via Getty Images
    Image attribution tooltip

    Roche inks deal for rights to Freenome cancer tests outside US

    Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits, similar to with their prior success in IVD kits.”

    By • Nov. 20, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott to acquire Exact Sciences for about $21B

    The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.

    By , • Updated Nov. 20, 2025
  • A picture of the exterior of a Labcorp building.
    Image attribution tooltip
    Courtesy of Labcorp
    Image attribution tooltip

    Labcorp inks deal to buy Parkview Health outreach laboratory assets

    The takeover extends a string of deals that have consolidated the outreach lab services market.

    By • Nov. 14, 2025
  • Sign outside Siemens building
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Siemens to reduce stake in Siemens Healthineers

    Siemens Healthineers CEO Bernd Montag said the decision is a “natural next step in our journey to becoming a fully independent company.”

    By • Nov. 13, 2025
  • The Olympus U.S. headquarters building is shown against a clear blue sky.
    Image attribution tooltip
    Retrieved from Olympus on February 03, 2025
    Image attribution tooltip

    Olympus to cut 2,000 jobs in endoscopy reorganization

    The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

    By • Nov. 7, 2025
  • A sign notes that the U.S. Capitol Visitor Center is closed due to the government shutdown, with the capitol building in the background.
    Image attribution tooltip
    Al Drago via Getty Images
    Image attribution tooltip

    Health groups urge passage of bill to ease Medicare pay cuts for tests

    More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent legislative solution to stop looming Medicare payment cuts for diagnostic tests.

    By • Nov. 3, 2025
  • A zoomed in picture to a person's eyes with glasses on
    Image attribution tooltip

     

    Hussey Photography, Tom Hussey

    Image attribution tooltip
    Sponsored by Danaher

    Turning aspirational innovations into tangible impacts

    Making tomorrow’s breakthroughs a reality for the patients who need.

    Nov. 3, 2025
  • A sign announces the company name at Agilent's headquarters building in Santa Clara, California.
    Image attribution tooltip
    Permission granted by Agilent
    Image attribution tooltip

    Agilent selects Adam Elinoff as CFO

    The appointment fills a position made available when Bob McMahon resigned as CFO on July 31.

    By • Oct. 31, 2025